The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
4-[(2S)-2-[(2S)-2-[(2S)-2-[4-(Guanidinomethyl)piperidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidine-1-carbonyl]pyrrolidin-1-yl]-N-(3-oxazol-5-ylphenyl)-4-oxo-butanamide ID: ALA5194506
Chembl Id: CHEMBL5194506
PubChem CID: 168284281
Max Phase: Preclinical
Molecular Formula: C35H47N9O6
Molecular Weight: 689.82
Associated Items:
Names and Identifiers Canonical SMILES: N=C(N)NCC1CCN(C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)[C@@H]2CCCN2C(=O)CCC(=O)Nc2cccc(-c3cnco3)c2)CC1
Standard InChI: InChI=1S/C35H47N9O6/c36-35(37)39-20-23-12-17-41(18-13-23)32(47)26-7-3-15-43(26)34(49)28-9-4-16-44(28)33(48)27-8-2-14-42(27)31(46)11-10-30(45)40-25-6-1-5-24(19-25)29-21-38-22-50-29/h1,5-6,19,21-23,26-28H,2-4,7-18,20H2,(H,40,45)(H4,36,37,39)/t26-,27-,28-/m0/s1
Standard InChI Key: DQFLGZKQGWZVON-KCHLEUMXSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 689.82Molecular Weight (Monoisotopic): 689.3649AlogP: 1.75#Rotatable Bonds: 10Polar Surface Area: 198.27Molecular Species: BASEHBA: 8HBD: 4#RO5 Violations: 1HBA (Lipinski): 15HBD (Lipinski): 5#RO5 Violations (Lipinski): 2CX Acidic pKa: 13.90CX Basic pKa: 12.14CX LogP: -1.37CX LogD: -3.68Aromatic Rings: 2Heavy Atoms: 50QED Weighted: 0.21Np Likeness Score: -1.02
References 1. Garsi JB, Komjáti B, Cullia G, Fejes I, Sipos M, Sipos Z, Fördős E, Markacz P, Balázs B, Lancelot N, Berger S, Raimbaud E, Brown D, Vuillard LM, Haberkorn L, Cukier C, Szlávik Z, Hanessian S.. (2022) Targeting NOX2 via p47/phox-p22/phox Inhibition with Novel Triproline Mimetics., 13 (6.0): [PMID:35707140 ] [10.1021/acsmedchemlett.2c00094 ]